Glia protect fetal midbrain dopamine neurons in culture from L-DOPA toxicity through multiple mechanisms M. A. MenaM. J. CasarejosJ. Garcia de Yébenes OriginalPaper Pages: 317 - 328
Amphetamine effects on dopamine release and synthesis rate studied in the Rhesus monkey brain by positron emission tomography P. HartvigR. TorstensonB. Långström OriginalPaper Pages: 329 - 339
Interactions between D1 and D2 dopamine receptor family agonists and antagonists: the effects of chronic exposure on behavior and receptor binding in rats and their clinical implications A. R. BraunM. LaruelleM. M. Mouradian OriginalPaper Pages: 341 - 362
6-Hydroxydopamine lesion of locus coeruleus and the antiparkinsonian potential of NMDA-receptor antagonists in rats N. RückertM. BubserW. J. Schmidt OriginalPaper Pages: 363 - 377
In vivo electrochemical measurements of serotonin clearance in rat striatum: effects of neonatal 6-hydroxydopamine-induced serotonin hyperinnervation and serotonin uptake inhibitors J. LuthmanM. N. FriedemannG. A. Gerhardt OriginalPaper Pages: 379 - 397
Mast cell specific proteases in rat brain: changes in rats with experimental allergic encephalomyelitis A. RouleauV. DimitriadouM. Garbarg OriginalPaper Pages: 399 - 417
The glycine antagonist (+)-HA-966 injected into the nucleus accumbens stimulates locomotion in mice M. NilssonM. L. Carlsson Rapid Communication Pages: 419 - 425
Electrophysiological evidence for visuocognitive dysfunction in younger non caucasian patients with Parkinson's disease L. SaglioccoF. BandiniI. Bodis-Wollner OriginalPaper Pages: 427 - 439
Concentration of catecholamines and indoleamines in the cerebrospinal fluid of patients with vascular parkinsonism compared to Parkinson's disease patients H. TohgiT. AbeT. Murata OriginalPaper Pages: 441 - 449
Concentrations of indoleamine metabolic intermediates in the ventricular cerebrospinal fluid of advanced Parkinson's patients with severe postural instability and gait disorders R. P. IaconoS. M. KuniyoshiR. D. Pearlstein OriginalPaper Pages: 451 - 459
Pergolide: treatment of choice in restless legs syndrome (RLS) and nocturnal myoclonus syndrome (NMS). A double-blind randomized crossover trial of pergolide versus L-Dopa J. StaedtF. WaβmuthG. Stoppe OriginalPaper Pages: 461 - 468
Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in mice J. LanD. H. Jiang OriginalPaper Pages: 469 - 481
EEG-microstates in mild memory impairment and Alzheimer's disease: possible association with disturbed information processing T. DierksV. JelicB. Winblad OriginalPaper Pages: 483 - 495
Neuronal APP accumulates in toxic membrane blebbings M. LesortF. TerroJ. Hugon OriginalPaper Pages: 497 - 513
Repeated administration of antidepressant drugs affects the levels of mRNA coding for D1 and D2 dopamine receptors in the rat brain M. Dziedzicka-WasylewskaR. RogożJ. Maj OriginalPaper Pages: 515 - 524
Antidepressant effects of pramipexole, a novel dopamine receptor agonist J. MajZ. RogóżK. Kołodziejczyk OriginalPaper Pages: 525 - 533
Does Ca2+ channel blockade modulate the antidepressant-induced changes in mechanisms of adrenergic transduction? I. NalepaM. KowalskaJ. Vetulani OriginalPaper Pages: 535 - 547
Cortical layer I changes in schizophrenia: a marker for impaired brain development? P. KalusD. SenitzH. Beckmann OriginalPaper Pages: 549 - 559
The apparent antipsychotic action of the 5-HT2a receptor antagonist M100907 in a mouse model of schizophrenia is counteracted by ritanserin P. MartinN. WatersM. L. Carlsson Rapid Communication Pages: 561 - 564